Summarized by Masters of Longevity from Frontiers - Health.
Metabolic oncology explores how long-term metabolic conditions shape premalignant cell selection and epigenetic priming, framing resistance as a pre-existing evolutionary process. Open this article to read a hypothesis-driven synthesis linking tissue metabolic states to early clonal dynamics and cancer resilience.
Key Takeaways
- Treatment resistance remains the principal cause of cancer mortality, conventionally modeled as an adaptive response arising under therapeutic pressure.
- However, a substantial component of resistance is plausibly established before therapeutic exposure, determined by the metabolic environment of the tissue in which the malignancy arises.
- Hyperinsulinemia and increased bioavailable IGF-1 sustain PI3K–AKT–mTOR and RAS–MAPK signaling in tissues where insulin resistance has preserved mitogenic sensitivity, creating an environment permissive to clonal selection.
